Pymepharco Joint Stock Company
Pymepharco Joint Stock Company, commonly referred to as Pymepharco, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1997, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions, including the southern provinces of Vietnam. Specialising in the manufacture of generic medicines, Pymepharco is renowned for its commitment to quality and innovation. The company offers a diverse range of products, including prescription medications and over-the-counter solutions, which are distinguished by their efficacy and safety. With a strong market position, Pymepharco has achieved notable milestones, including certifications from international health authorities, solidifying its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Pymepharco Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pymepharco Joint Stock Company's score of 24 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pymepharco Joint Stock Company's reported carbon emissions
Pymepharco Joint Stock Company, headquartered in Vietnam, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Pymepharco to establish clear emissions reduction goals and commitments to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pymepharco Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
